NASDAQ:ANGN
Delisted

Angion Biomedica Stock Signals

etoro logo Buy ANGN
*Your capital is at risk
$1.00
+0 (+0%)
At Close: Aug 31, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Angion Biomedica Corp.

General

Signal Type Signal Value Data
Score 0.000 86 days ( -49.25 %
Last Price $1.00 0 %
Performance History
7 Days
$1.00 $1.00
0%
30 Days
$1.00 $1.00
0%
12 Mos
$1.02 $1.00
-1.96%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.00 - $1.00
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Aug 30, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Jun 14, 2023 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.33
Signal Type Signal Value Importance Data
Trend - 12 mos -0.321 % Very High Width: 156.36 %
Pred. range - 12 mos $0.477 - $1.22 High -52.32 % - 22.22 %
Short MA 12 mos Buy Very High Apr 12, 2023 - 99 days
Long MA 12 mos Buy Very High May 03, 2023 - 84 days
Short/Long MA 12 mos Buy Very High May 05, 2023 - 82 days
Pivot Long Sell Low Aug 30, 2023 - 2 days
RSI Long Pivot Signal Sell Low Jun 26, 2023 - 48 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ANGION BIOMEDICA CORP.
Angion Biomedica
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute ...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE